Serum D‐2‐hydroxyglutarate and the ratio of D‐2HG/L‐2HG predict IDH mutation in acute myeloid leukemia
Abstract This study investigates whether serum D‐2HG (D‐2‐hydroxyglutarate) produced by the mutated isocitrate dehydrogenase (IDH) can predict IDH mutations in acute myeloid leukemia (AML) at diagnosis. D‐2HG and L‐2HG are measured by liquid chromatography‐tandem mass spectrometry. D‐2HG, total 2HG...
Main Authors: | Chelsea Zhang, Andrew Chu, Richard Boriack, Robert Collins, Jing Xu, Dwight Oliver, Ruifang Zheng, Dinesh Rakheja, Weina Chen |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2023-08-01
|
Series: | eJHaem |
Subjects: | |
Online Access: | https://doi.org/10.1002/jha2.723 |
Similar Items
-
Clinical usefulness of 2-hydroxyglutarate as a biomarker in IDH-mutant chondrosarcoma
by: Makoto Nakagawa, et al.
Published: (2022-06-01) -
A bacterial enzyme may correct 2-HG accumulation in human cancers
by: William J. Yin, et al.
Published: (2023-07-01) -
Quantitative imaging of D-2-hydroxyglutarate (D2HG) in selected histological tissue areas by a novel bioluminescence technique
by: Nadine Fabienne Voelxen, et al.
Published: (2016-03-01) -
Lactonization of the Oncometabolite D-2-Hydroxyglutarate Produces a Novel Endogenous Metabolite
by: Raffaela S. Berger, et al.
Published: (2021-04-01) -
Teleological role of L-2-hydroxyglutarate dehydrogenase in the kidney
by: Garrett Brinkley, et al.
Published: (2020-11-01)